10-Q: Hamilton Beach Brands Reports Q2 Revenue Decline Amid Retailer Inventory Adjustments and Tariffs
Quarterly Report
Hamilton Beach Brands Holding Company experienced an 18.2% revenue decrease in the second quarter of 2025, primarily due to lower U.S. consumer volumes and new tariffs, despite an improved gross profit margin.
Summary
- Revenue for the three months ended June 30, 2025, decreased by $28.5 million, or 18.2%, to $127.8 million compared to $156.2 million in the prior year.
- Gross profit margin increased to 27.5% in Q2 2025 from 25.9% in Q2 2024, driven by a shift in U.S. Consumer business customer mix, higher-margin International Commercial business sales, and HealthBeacon contributions.
- Net income for the three months ended June 30, 2025, was $4.5 million, a 25.6% decrease from $6.0 million in the prior year.
- Basic and diluted earnings per share for Q2 2025 were $0.33, down from $0.42 in Q2 2024.
- For the six months ended June 30, 2025, revenue decreased by $23.4 million, or 8.2%, to $261.1 million.
- Net income for the six months ended June 30, 2025, increased by 29.7% to $6.3 million, up from $4.8 million in the prior year, largely due to a lower effective tax rate.
- Operating cash flow for the six months ended June 30, 2025, was a net cash outflow of $23.8 million, a significant decline from a $37.1 million inflow in the prior year, primarily due to a $50.8 million change in inventory and accounts payable.
- The company repurchased 215,297 shares for $4.0 million in Q2 2025 and 356,732 shares for $6.7 million in H1 2025 under its stock repurchase program, with $4.8 million remaining authorized.
- The Health segment, acquired in February 2024, contributed $1.7 million in revenue and incurred an operating loss of $0.7 million in Q2 2025.
- The effective income tax rate decreased to 25.9% for Q2 2025 and 26.7% for H1 2025, primarily due to reduced non-deductible expenses and a decreased impact of the HealthBeacon valuation allowance.
Sentiment
Score: 4
Explanation: The sentiment is moderately negative due to significant revenue declines, a substantial negative shift in operating cash flow, and reduced operating profit in the quarter. While gross margins improved and SG&A decreased, the overall financial performance indicates a challenging period influenced by external factors like tariffs and retailer inventory adjustments. The HealthBeacon segment, while growing, remains unprofitable.
Positives
- Gross profit margin improved to 27.5% in Q2 2025 (from 25.9% in Q2 2024) and 26.0% in H1 2025 (from 24.8% in H1 2024) due to favorable customer mix, higher-margin International Commercial business, and HealthBeacon sales.
- Selling, general and administrative expenses decreased by $1.3 million in Q2 2025 and $1.9 million in H1 2025, primarily due to lower incentive-related personnel costs.
- Net income for the six months ended June 30, 2025, increased by 29.7% to $6.3 million, driven by a lower effective tax rate.
- The effective income tax rate decreased significantly to 25.9% in Q2 2025 and 26.7% in H1 2025, compared to 33.2% and 37.2% respectively in the prior year, due to reduced non-deductible expenses and a decreased impact of the HealthBeacon valuation allowance.
- The company continues its stock repurchase program, demonstrating confidence in its share value, with $4.8 million remaining authorized.
- The company maintains sufficient liquidity with $45.4 million in Excess Availability under its $125.0 million revolving credit facility.
- The U.S. Pension Plan termination was substantially completed in 2024, with surplus assets transferred to a qualified replacement plan.
Negatives
- Total revenue decreased by 18.2% in Q2 2025 and 8.2% in H1 2025, primarily due to lower volumes in the U.S. Consumer business.
- Operating profit decreased by 40.3% in Q2 2025 to $5.9 million and by 8.3% in H1 2025 to $8.3 million.
- Net income for Q2 2025 decreased by 25.6% to $4.5 million.
- Net cash used for operating activities was $23.8 million for the six months ended June 30, 2025, a significant decline from $37.1 million provided in the prior year, primarily due to changes in inventory and accounts payable.
- Inventory increased by $33.6 million for the six months ended June 30, 2025, reflecting higher values due to increased tariffs and accelerated purchases, leading to slower inventory turnover.
- The HealthBeacon segment continues to operate at a loss, with an operating loss of $0.7 million in Q2 2025 and $1.4 million in H1 2025.
Risks
- Uncertain or unfavorable global economic conditions, including impacts from tariffs, inflation, rising interest rates, recessions, or economic slowdowns.
- Changes in costs, including transportation costs and tariffs, of sourced products.
- Ability to source and ship products to meet anticipated demand.
- Changes in or unavailability of quality or cost-effective suppliers.
- Ability to successfully manage constraints throughout the global transportation supply chain.
- Delays in delivery of sourced products.
- Changes in the sales prices, product mix, or levels of consumer purchases of small electric and specialty housewares appliances.
- Changes in consumer retail and credit markets, including the increasing volume of transactions made through third-party internet sellers.
- Bankruptcy of or loss of major retail customers or suppliers.
- Exchange rate fluctuations, changes in import tariffs and monetary policies, and other changes in the regulatory climate in countries of operation.
- Impact of tariffs on customer purchasing patterns.
- Customer acceptance of changes in costs of or delays in the development of new products.
- Product liability, regulatory actions or other litigation, warranty claims, or returns of products.
- Increased competition, including consolidation within the industry.
- Changes in customers' inventory management strategies.
- Shifts in consumer shopping patterns, gasoline prices, weather conditions, consumer confidence, and disposable income.
- Changes mandated by federal, state, and other regulation, including tax, health, safety, or environmental legislation.
- Ability to identify, acquire or develop, and successfully integrate, new businesses or new product lines.
Future Outlook
The company anticipates its revenue will typically increase during the second half of the year, peaking in the fourth quarter due to the fall holiday-selling season. While many retailers have resumed buying after pausing in Q2 2025, the future impact of tariff-related price increases on consumer demand remains uncertain. The company believes current cash on hand, the HBB Facility, and operating cash flows will provide sufficient liquidity for the next twelve months. The company does not expect to make voluntary repayments on the HBB Facility within the next twelve months unless interest rates materially decrease.
Management Comments
- The revenue decline was primarily driven by lower volumes in the U.S. Consumer business as some retailers paused buying in the second quarter in order to assess inventory levels and price increases flowing from the new tariffs implemented by the United States in April 2025.
- While many retailers have resumed buying, the future tariff related impacts on consumer demand remain uncertain.
- The decrease in Selling, General and Administrative expenses was primarily driven by lower incentive related personnel costs, partially offset by a one-time severance charge from restructuring actions taken by management to deleverage its cost structure.
- The significant decrease in net cash provided by operating activities was primarily driven by a $50.8 million change in inventory and accounts payable, reflecting higher inventory values due to increased tariffs and the acceleration of material inventory purchases in the first quarter of 2025, combined with lower sales, leading to a slowdown in inventory turnover.
Industry Context
The small electric household and specialty housewares appliance market is characterized by seasonal demand, with revenue typically peaking in the fourth quarter due to holiday sales. The industry is currently navigating challenges from new tariffs, which have led to price increases and cautious buying behavior from retailers assessing inventory levels. The company's expansion into the health segment with HealthBeacon reflects a diversification strategy into connected devices and software for home healthcare management, a growing but currently loss-making area for the company.
Comparison to Industry Standards
- NA The filing does not provide specific comparable companies, projects, or results to benchmark against industry standards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Assessment Scope | HealthBeacon, acquired on February 2, 2024, is currently being integrated and will be included in management's evaluation of internal control over financial reporting as of December 31, 2025. | 2025-12-31 | This indicates a phased approach to integrating the acquired entity into the company's control framework, with full inclusion expected by year-end, ensuring compliance with SEC rules. |
Legal Proceedings
- The company is involved in various legal and regulatory proceedings and claims in the ordinary course of business, including product liability, patent infringement, environmental, and other claims.
- Accrued undiscounted obligations for environmental investigation and remediation activities were $3.2 million as of June 30, 2025.
- It is reasonably possible that the company may incur additional environmental expenses in the range of zero to $1.0 million.
- As of June 30, 2025, the company has a $0.8 million asset associated with the reimbursement of costs for two environmental sites.
Stakeholder Impact
- Shareholders: Impacted by decreased earnings per share and negative operating cash flow, though partially offset by continued share repurchases and improved gross margins.
- Customers (Retailers): Experienced paused buying due to inventory assessment and new tariffs, indicating potential shifts in purchasing patterns and pricing strategies.
- Employees: Affected by lower incentive-related personnel costs and a one-time severance charge from restructuring actions, suggesting cost-cutting measures.
- Suppliers: Involved in a supplier finance program, with $32.0 million in payment obligations sold by participating suppliers as of June 30, 2025, indicating reliance on third-party financing for some suppliers.
Next Steps
- Continue to manage inventory levels and adapt to retailer buying patterns, especially concerning tariff impacts.
- Integrate HealthBeacon into operations and internal control processes, with full assessment expected by December 31, 2025.
- Monitor global economic conditions, including inflation, interest rates, and consumer spending, for potential impacts on business.
Key Dates
| Date | Description |
|---|---|
| 2022-09-30 | Effective date of the U.S. Pension Plan termination. |
| 2023-11-01 | Company's Board approved a stock repurchase program for up to $25 million of Class A Common stock. |
| 2024-01-01 | Start date for the $25 million stock repurchase program. |
| 2024-02-02 | Completion of the acquisition of HealthBeacon for approximately $7.5 million. |
| 2024-03-05 | 30 mandatory cashless-exercise-award shares of Class A Common were surrendered to the company by participants of the Executive Long-Term Equity Incentive Compensation Plan to satisfy tax withholding obligations. |
| 2024-12-13 | Expiration date of the $125.0 million senior secured floating-rate revolving credit facility (HBB Facility). |
| 2024-12-31 | Purchase price allocation for HealthBeacon was finalized. |
| 2025-02-21 | 39 mandatory cashless-exercise-award shares of Class A Common were surrendered to the company by participants of the Executive Long-Term Equity Incentive Compensation Plan to satisfy tax withholding obligations. |
| 2025-04-01 | New tariffs implemented by the United States, impacting consumer business. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-25 | Number of shares of Class A and Class B Common Stock outstanding reported as of this date. |
| 2025-12-31 | End date for the $25 million stock repurchase program. |
| 2025-12-31 | HealthBeacon will be included in management's evaluation of internal control over financial reporting as of this date. |
Recommendation
holdWhile the company experienced a significant revenue decline and negative operating cash flow, which are concerning, there are mitigating factors. Gross profit margins improved, and management implemented cost-cutting measures through SG&A reductions and restructuring. The company also continues its share repurchase program, signaling management's belief in the stock's value. The challenges appear to be largely external (tariffs, retailer inventory adjustments) rather than fundamental operational failures. Given the mixed signals and the potential for recovery in the second half of the year as retailers resume buying, a 'Hold' recommendation is appropriate, suggesting investors monitor the situation closely for signs of stabilization and improved cash generation.
Keywords
Small Appliances, Household Appliances, Commercial Products, Health Technology, SEC Filing, Quarterly Report, Consumer Goods, Tariffs, Inventory Management, Financial Results, Stock Repurchase, Supply Chain, Revenue, Profit, Cash Flow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.